Case report: A case of complete clinical response in a patient experiencing high microsatellite instability unresectable colon cancer being treated with a PD-L1 inhibitor after interstitial pneumonia

Immune checkpoint inhibitors (ICI) have dramatically transformed the treatment landscape for metastatic colorectal cancer (mCRC) with deficient DNA mismatch repair (dMMR) or high microsatellite instability (MSI-H). Envafolimab, a novel programmed death-1 ligand 1 (PD-L1) inhibitor, has been reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Luo, Mou, Haibo, Hou, Xuehua, Liao, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043298/
https://www.ncbi.nlm.nih.gov/pubmed/36998453
http://dx.doi.org/10.3389/fonc.2023.1126769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043298/
https://www.ncbi.nlm.nih.gov/pubmed/36998453
http://dx.doi.org/10.3389/fonc.2023.1126769

Ejemplares similares